Advertisement

Archives of oto-rhino-laryngology

, Volume 246, Issue 5, pp 373–377 | Cite as

Induction chemotherapy with cisplatinum, 5-fluorouracil, bleomycin, mitomycin C and hydroxyurea for previously untreated locally advanced squamous cell carcinomas of the head and neck

  • G. Fountzilas
  • A. Nicolaou
  • K. Sridhar
  • T. Sideras
  • A. Haritanti
  • C. Anastasakis
  • V. Delis
  • A. Vritsios
  • J. Daniilidis
Cancer

Summary

Fifty-three patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) were treated with a combined modality treatment consisting of three cycles of induction chemotherapy before definitive surgery and/or radiotherapy. Two additional cycles of the same chemotherapy were given after local-regional therapy. The chemotherapeutic regimen included cisplatinum 100 mg/m2 on day 1, 5-fluorouracil 1000 mg/m2 as a continuous infusion on days 2–6, bleomycin 15 units i.m. on days 15 and 29, mitomycin C 4 mg/m2 i.v. on day 22 and hydroxyurea 1000 mg/m2 p.o. on days 23–27. Each cycle was repeated every 42 days.

Forty-nine patients are evaluable for response. There were 37 men and 12 women, with a median age of 58 years (range 18–75 years) and performance status of 80 (range 40–90). Sixteen patients (33%) demonstrated a complete response, 20 (41%) a partial response, yielding a 74% response rate to induction chemotherapy; 12 (24%) patients had stable disease and 1 (2%) progressive disease. The actuarial survival of those patients who completed the whole treatment program was 65% at 2 years and 47% at 3 years. Toxicities included nausea and vomiting (66%), anemia (34%), leukocytopenia (54%), thrombocytopenia (22%), stomatitis (36%), diarrhea (10%), alopecia (78%), hear impairment (4%) and transient creatinine elevation (2%). The results of the present study showed that induction chemotherapy with the above regimen produced a high rate of complete responses and can be safely combined with local-regional therapy to improve local tumor control and increase disease-free survival in patients with locally advanced SCCHN.

Key words

Induction chemotherapy Head and neck cancer Cisplatinum 5-Fluorouracil 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O, Kirkpatrick A, Rozencweig M (1987) Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck. Cancer 60:1173–1177Google Scholar
  2. 2.
    Dasmahapatra KS, Citrin P, Hill GJ, Yee R, Mohit-Tabatabai MA, Rush BF Jr (1985) A prospective evaluation of 5-fluorouracil plus cisplatin in advanced squamous cell cancer of the head and neck. J Clin Oncol 3:1486–1489Google Scholar
  3. 3.
    Dodion P, Cognetti F, Van Rymenant M, Dalesio O, Kirkpatrick A, Rozencweig M (1986) Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carinoma of the head and neck. Eur J Cancer Clin Oncol 22:241–243Google Scholar
  4. 4.
    Ensley JF, Jacobs JR, Weaver A, Kinzie J, Crissman J, Kish JA, Cummings G, Al-Sarraf M (1984) Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811–814Google Scholar
  5. 5.
    Ervin TJ, Clark JR, Weichselbaum RR (1985) Multidisciplinary treatment of advanced squamous carcinoma of the head and neck. Semin Oncol 12:71–78Google Scholar
  6. 6.
    Ervin TJ, Clark JR, Weichselbaum RR, Fallon BG, Miller D, Fabian RL, Posner MR, Norris CM, Tuttle SA, Shoenfeld DA, Price KN, Frei E III. (1987) An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous — cell carcinoma of the head and neck. J Clin Oncol 5:10–20Google Scholar
  7. 7.
    Gasparini M, Lombardi F, Rottoli L, Ballerini E, Morandi F (1988) Combined radiotherapy and chemotherapy in stage T3 and T4 nasopharyngeal carcinoma in children. J Clin Oncol 6:491–494Google Scholar
  8. 8.
    Glick JH, Marcial V, Richter M, Velez-Garcia E (1980) The adjuvant treatment of inoperable stage III and IV epidermoid carcinoma of the head and neck with platinum and bleomycin infusions prior to definitive radiotherapy. Cancer 46:1919–1924Google Scholar
  9. 9.
    Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE (1987) Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer. Cancer 60:1178–1183Google Scholar
  10. 10.
    Lerner HJ, Beckloff GL, Godwin MC (1969) Hydroxyurea (NSC-32065) intermittent therapy in malignant disease. Cancer Chemother Rep 53:385–395Google Scholar
  11. 11.
    Merino OR, Lindberg RD, Fletcher GH (1977) An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40:145–151Google Scholar
  12. 12.
    Million RR, Cassisi NJ (eds) (1984) Management of head and neck cancer. A multidisciplinary approach. Lippincott, PhiladelphiaGoogle Scholar
  13. 13.
    Rahima M, Rakowsky E, Barzilay J, Sidi J (1986) Carcinoma of the nasopharynx. An analysis of 91 cases and a comparison of differing treatment approaches. Cancer 58:843–849Google Scholar
  14. 14.
    Rooney M, Kish J, Jacobs J, Kinzie J, Weaver A, Crissman J, Al-Sarraf M (1985) Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120-hour 5-FU infusion and cisplatin. Cancer 55:1123–1128Google Scholar
  15. 15.
    Schuller DE, Wilson HE, Smith RF, Batley F, James AD (1983) Preoperative reductive chemotherapy for locally advanced carcinoma of the oral cavity, oropharynx, and hypopharynx. Cancer 51:15–19Google Scholar
  16. 16.
    Silverberg E (1982) Cancer statistics. CA 32:15–31Google Scholar
  17. 17.
    Spaulding M, Ziegler P, Sundanist N, Klotch D, Lee K, Khan A, Lore J (1986) Induction therapy in head and neck cancer. A comparison of two regimens. Cancer 57:1110–1114Google Scholar
  18. 18.
    Sridhar KS, Donnelly E (1988) Combination antiemetics for cisplatin chemotherapy. Cancer 61:1508–1517Google Scholar
  19. 19.
    Sridhar KS, Hirsch R, Fountzilas G, Goodwin WJ, Robinson D, Broder LE (1984) Sequential cisplatin and 5-fluorouracil in advanced squamous cell head and neck cancer. Proc Am Assoc Cancer Res 25:180Google Scholar
  20. 20.
    Tannock I, Payne D, Cummings B, Hewitt K, Panzarella T, and Princess Margaret Hospital Head and Neck Cancer Group (1987) Sequential chemotherapy and radiation for nasopharyngeal cancer: absence of long-term benefit despite a high rate of tumor response to chemotherapy. J Clin Oncol 5:629–634Google Scholar
  21. 21.
    Vikram B, Strong EW, Shah JP, Spiro R (1984) Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6:730–733Google Scholar
  22. 22.
    Weaver A, Flemming S, Kish J, Vandenberg H, Jacob J, Crissman J, Al-Sarraf M (1982) Cis-platinum and 5-fluorouracil as induction therapy for advanced head and neck cancer. Am J Surg 144:445–448Google Scholar
  23. 23.
    Weibull N (1939) A statistical theory of the strength of materials. Ingeniörs Vetenskaps Akademien, Handlingar, no 151Google Scholar

Copyright information

© Springer-Verlag 1989

Authors and Affiliations

  • G. Fountzilas
    • 1
  • A. Nicolaou
    • 2
  • K. Sridhar
    • 5
  • T. Sideras
    • 4
  • A. Haritanti
    • 3
  • C. Anastasakis
    • 2
  • V. Delis
    • 2
  • A. Vritsios
    • 3
  • J. Daniilidis
    • 2
  1. 1.Department of MedicineAHEPA University HospitalThessalonikiGreece
  2. 2.Department of OtolaryngologyAHEPA University HospitalThessalonikiGreece
  3. 3.Department of RadiologyAHEPA University HospitalThessalonikiGreece
  4. 4.Department of OtolaryngologyTheagenion Cancer InstituteThessalonikiGreece
  5. 5.Division of Pulmonary OncologyPapanicolaou Comprehensive Cancer CenterMiamiUSA

Personalised recommendations